Trobix Bio

Trobix Bio is a company that develops and commercializes antibacterial products. Trobix Bio holds unique proprietary patents in phage-based antibiotic resistance sensitization solutions. The company’s most advanced active sensitization technology, ActiSense™, applies selective pressure to reverse antibiotic resistance, addressing the core issue of the spread of antibiotic-resistant bacteria. The company's proprietary GOTraP™ DNA delivery technology significantly extends DNA transduction into targeted bacterial hosts. Trobix Bio has the global exclusive license for this technology, which was invented by Professor Udi Qimron and his team at Tel Aviv University in Israel.